HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 18 filers reported holding HUMACYTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $169,724 | -1.7% | 236,549 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $172,681 | +121506.3% | 236,549 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $142 | +52.7% | 236,549 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $93 | -100.0% | 236,549 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $263,000 | +26.4% | 236,549 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $208,000 | -54.9% | 236,549 | 0.0% | 0.01% | -54.5% |
| Q1 2022 | $461,000 | -14.5% | 236,549 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $539,000 | -21.3% | 236,549 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $685,000 | – | 236,549 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RPO LLC | 81,705 | $159,000 | 0.05% |
| CVI Holdings, LLC | 269,138 | $517,000 | 0.03% |
| Sio Capital Management, LLC | 49,998 | $97,000 | 0.03% |
| Alpine Global Management, LLC | 95,000 | $182,000 | 0.02% |
| Exos Asset Management LLC | 27,151 | $53,000 | 0.02% |
| TUDOR INVESTMENT CORP ET AL | 236,549 | $461,000 | 0.01% |
| LMR Partners LLP | 50,000 | $353,000 | 0.00% |
| P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $37,000 | 0.00% |
| Diameter Capital Partners LP | 19,085 | $37,000 | 0.00% |
| HRT FINANCIAL LP | 50,250 | $96,000 | 0.00% |